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ABSTRACT
Toxin–antitoxin (TA) complexes function in pro-
grammed cell death or stress response mecha-
nisms in bacteria. The YefM–YoeB TA complex of
Escherichia coli consists of YoeB toxin that is
counteracted by YefM antitoxin. When liberated
from the complex, YoeB acts as an endoribonucle-
ase, preferentially cleaving 30 of purine nucleotides.
Here we demonstrate that yefM-yoeB is transcrip-
tionally autoregulated. YefM, a dimeric protein with
extensive secondary structure revealed by circular
dichroism (CD) and nuclear magnetic resonance
(NMR) spectroscopy, is the primary repressor,
whereas YoeB is a repression enhancer. The opera-
tor site 50 of yefM-yoeB comprises adjacent long and
short palindromes with core 50-TGTACA-30 motifs.
YefM binds the long palindrome, followed sequen-
tially by short palindrome recognition. In contrast,
the repressor–corepressor complex recognizes both
motifs more avidly, impyling that YefM within the
complex has an enhanced DNA-binding affinity
compared to free YefM. Operator interaction by
YefM and YefM–YoeB is accompanied by structural
transitions in the proteins. Paired 50-TGTACA-30
motifs are common in yefM-yoeB regulatory regions
in diverse genomes suggesting that interaction of
YefM–YoeB with these motifs is a conserved mecha-
nism of operon autoregulation. Artificial perturbation
of transcriptional autorepression could elicit inap-
propriate YoeB toxin production and induction of
bacterial cell suicide, a potentially novel antibacterial
strategy.
INTRODUCTION
Bacteria populate and thrive in remarkably diverse environ-
mental conditions and ecological niches. However, bacterial
species may need to adapt rapidly to dramatic changes in
nutritional or physiological circumstances. For example,
intestinal bacteria must adjust to cycles of nutriment excess
and starvation, and soil and other microorganisms may
need to cope with oscillating periods of dessication and
hydration (1,2). Moreover, when passaging between exponen-
tial growth and stationary phase, the production of diverse
macromolecules and cell components decelerates at different
rates (3). Furthermore, bacteria generally exist as multicellu-
lar colonies (4) or as bioﬁlms (5). Within these microenviron-
ments, intercellular signalling and coordinated multicellular
processes are mediated by quorum-sensing mechanisms that
regulate a diverse array of physiological activities (6). Even
at the colonial level bacteria maintain discrete, ordered spatial
structures (4).
The concept that bacteria possess programmed cell death
or cell cycle arrest mechanisms that interconnect with com-
plex physiological networks and multicellular organization
has emerged relatively recently, but has been validated by
observations that the genome of Escherichia coli K12, for
example, harbours a number of toxin–antitoxin (TA) mod-
ules. These modules are involved in the response to nutrient
deprivation or other stresses (7). Other bacterial genomes also
contain multiple putative TA cassettes (8). Remarkably, some
bacteria harbour 10s of TA modules, including some species
that possess >40 distinct TA loci (9). These modules are orga-
nized similarly and are homologous to TA cassettes that pro-
mote plasmid maintenance by post-segregational killing of
plasmid-free cells, indicating extensive module transfer
between plasmid and chromosome genomes (7). In plasmid-
speciﬁed complexes, the antitoxin is more susceptible to host
proteases than is the toxin. When a plasmid-free cell arises
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antitoxin and targets an essential intracellular host factor to
cause cell death or severe growth impairment. Chromosomal
TA activity in bacteria might be triggered in response to star-
vation conditions, bacteriophage infection exposure to anti-
microbial agents, DNA damage and other physiological
stresses. Under these circumstances it may be beneﬁcial to
the community to sacriﬁce a portion of the cells within it
so that a sub-population can persist, perhaps even cannabiliz-
ing nutrients that dead cells have released (10,11). Alterna-
tively, by acting as reversible cell cycle arrest agents, TA
factors might allow cells to enter a dormant or semidormant
state as a protection against temporary nutrient limitation
and to revive when physiological conditions become more
conducive (12).
The two most well characterized chromosomal TA factors
are RelBE and MazEF of E.coli. RelE toxin is a global
inhibitor of translation that is activated during amino acid
starvation but which is otherwise counteracted by RelB anti-
toxin (13). RelE is an endoribonuclease that, although it does
not degrade free RNA, cleaves mRNA in the ribosomal A site
with high-codon speciﬁcity (12). Production of the MazEF
proteins is regulated by the alarmone guanosine-3050-
bispyrophosphate (ppGpp) that is synthesized by RelA pro-
tein under conditions of amino acid starvation. Moreover,
overproduction of ppGpp induces MazEF-mediated cell
death (14). MazF, like RelE, is an endoribonuclease that
cleaves mRNA site-speciﬁcally, although without a require-
ment that the mRNA be associated with the ribosome
(15,16). MazEF, like RelBE, might be responsible for death
in starving cultures of E.coli (14). Cell death mediated by
MazEF can also be triggered by several antibiotics that are
general inhibitors of transcription and/or translation. In con-
trast, it has been proposed that the MazF toxin does not
induce cell killing, but instead is a bacteriostatic agent from
which cells can recover when more conducive conditions
prevail (17).
Pomerantsev et al. ﬁrst proposed that yefM-yoeB in E.coli
speciﬁed a TA complex, based on homology between YefM
and the Phd antitoxin encoded by bacteriophage P1 (18).
YefM–YoeB was subsequently shown to be a functional
TA related to the Axe–Txe complex encoded by enterococ-
cal, multidrug resistance plasmid pRUM, and that YefM–
YoeB homologues are widely-distributed on bacterial
genomes (19). The YefM antitoxin forms a heterotrimeric
complex with the YoeB toxin (20,21). YoeB is an
endoribonuclease, like RelE and MazF, cleaving preferen-
tially at the 30 side of adenine and guanine nucleotides
(21,22). Overproduction of Lon ATP-dependent protease spe-
ciﬁcally activates this cleavage. This probably occurs due to
the liberation of YoeB from its tight association with YefM,
the latter failing to be replenished due to Lon-mediated trans-
lation inhibition of a YoeB-independent pathway (22). Inter-
estingly, the yefM gene is upregulated during growth of E.coli
in bioﬁlms (23).
The tertiary structures of YoeB and the YefM2–YoeB com-
plex have recently been described (21). One of the C-termini
in the YefM homodimer is unstructured, whereas the other
C-terminus adopts an a-helical conformation within the
heterotrimeric complex and conceals the atypical ribonucle-
ase fold of YoeB. The N-terminal regions of YefM form a
symmetrical dimer within the YefM2–YoeB complex and
do not contact YoeB directly in the crystal structure (21),
although the YefM recognition determinant that interacts
most strongly with YoeB was previously mapped to the
N-terminal segment of the protein (24). The three residues
at the C-terminal tip of YoeB that form part of the atypical
endoribonucleolytic fold are rearranged into a less favourable
conformation when in complex with the YefM dimer, partly
explaining the mechanism by which the antitoxin blocks the
toxic activity of YoeB (21).
Controlled activation of the toxin factor is paramount to
the function of TA complexes. Transcriptional autoregulation
of TA cassettes is one level at which this control is exerted
(25–33). Here we dissect the role of the YefM–YoeB com-
plex in modulating its own synthesis: YefM is the primary
transcriptional repressor of the yefM-yoeB cassette, with
YoeB acting as a repression enhancer. DNA binding is
achieved by the association of the proteins with a pair of
palindromes that comprise the yefM-yoeB operator site.
Understanding the molecular basis of yefM-yoeB regulation
may suggest strategies for perturbing this control, leading
to the production of excess intracellular toxin and therefore
controlled bacterial cell suicide.
MATERIALS AND METHODS
Strains
E.coli DH5a was used for plasmid construction and RNA iso-
lation, BL21(DE3) for recombinant YefM and YefM–YoeB
overproduction, and SC301467 (22) for b-galactosidase
assays. Bacteria were grown in Luria–Bertani (LB) medium
at 37 C. Antibiotics were added at ﬁnal concentrations of
100 mg/ml (ampicillin) and 34 mg/ml (chloramphenicol).
Plasmids and oligonucleotides
Oligonucleotides and plasmids used in this study are listed in
Tables 1 and 2, respectively.
Protein production and purification
The yefM and the yefM-yoeB genes were ampliﬁed by PCR
using oligonucleotides 8/10 and 8/13, respectively, and
cloned separately between NdeI and XhoI restriction ezyme
sites in the pET-22b(+) overexpression vector (Novagen) to
produce proteins C-terminally-tagged with a hexahistidine
motif. The yefM gene was also ampliﬁed using oligonu-
cleotides 8/9 and cloned in pET-16b for production of an
N-terminally-tagged derivative and, using oligonucleotides
8/11, as an NdeI–SapI fragment in pTYB1 (New England
Biolabs) to generate an intein fusion protein. The yefM-
yoeB cassette was also ampliﬁed with oligonucleotides 8/12
for insertion in pET-16b. His-tagged proteins were overpro-
duced in E.coli BL21(DE3) and puriﬁed by Ni
2+ afﬁnity chro-
matography essentially according to the Novagen technical
manual. Protein concentrations in samples containing puriﬁed
YefM–YoeB complex were estimated using a 2:1 ratio of
YefM:YoeB (21).
The YefM–intein fusion protein was overproduced and
the intein tag cleaved as follows. 300 ml of strain BL21
harbouring the expression plasmid was grown at 37 C until
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b-D-thiogalactopyranoside (IPTG) and shifted to 25 C, and
growth continued overnight. Cells were harvested at 1250 g
at 4 C for 10 min. The pellet was resuspended in 10 ml of
binding buffer A [20 mM Tris–HCl (pH 8.5), 500 mM
NaCl and 1 mM EDTA], the cells were sonicated, and then
centrifuged for 1 h at 25000 g at 4 C. The supernatant was
applied to a column containing 5 ml of chitin resin (New
England Biolabs) and equilibrated with buffer A. Binding
of the fusion protein to the chitin resin was allowed to con-
tinue for 3 h at 4 C after which the column was washed
with 80 ml of buffer A, and then quickly ﬂushed with 9 ml
of buffer A with 50 mM DTT. The column was closed to
allow cleavage of the intein tag for 21 h at 4 C. Elution
was performed with 7 ml of buffer A and 1 ml fractions
were collected. Fractions containing native YefM protein
were combined and dialysed against 1 l of storage buffer
[50 mM Tris–HCl (pH 8.5), 150 mM NaCl and 10% gly-
cerol], and then aliquoted and stored at  80 C.
For puriﬁcation of untagged YoeB, 300 ml of E.coli BL21
harbouring a pET16b plasmid producing His10-YefM–YoeB
were grown at 37 C until OD600   0.8. Expression of the
complex was induced with 1 mM IPTG and incubation con-
tinued for 3 h. Cells were harvested at 1250 g at 4 C for
10 min. The pellet was resuspended in 10 ml of buffer A
with lysozyme (0.1 mg/ml) and phenylmethylsulfonyl ﬂuo-
ride (PMSF) (1 mM), the cells were sonicated, and then cen-
trifuged for 1 h at 25 000 g at 4 C. The supernatant was
applied to a column consisting of 3 ml of His-tag resin
(Novagen) equilibrated with buffer B [20 mM Tris–HCl
(pH 8.0), 10 mM imidazole and 500 mM NaCl]. Binding of
His10-YefM–YoeB to the resin was continued for 1–2 h at
4 C. The column was washed with 60 ml of buffer B, and
then with 50 ml of wash buffer C [20 mM Tris–HCl (pH
8.0), 100 mM imidazole and 500 mM NaCl]. Denaturation
and elution of YoeB from the column was performed with
10 ml of buffer D [20 mM Tris–HCl (pH 8.0), 6 M guanidine-
hydrochloride, 10 mM imidazole and 500 mM NaCl]. 1 ml
fractions were collected, and fractions containing the highest
concentrations of denatured YoeB were pooled and dialysed
successively for 2 h against 500 ml volumes of 20 mM
Table 1. Oligonucleotides used in this study
Oligonucleotide Sequence (50–30) (length [nt])
a
1 GTCGAGAATTCTCTACAAACTAATTAATAAATA-
GTTAATTAACGCTCATCATTGTACAATGAACT-
GTACAAAAGAGGAGATTGACATGGGATCCAG-
TGC (99)
2 GCACTGGATCCCATGTCAATCTCCTCTTTTGTAC-
AGTTCATTGTACAATGATGAGCGTTAATTAAC-
TATTTATTAATTAGTTTGTAGAGAATTCTC-
GAC (99)
3 GTCGAGAATTCTCTACAAACTAATTAATAAATA-
GTTAATTAACGCTCATCATTGTACAATGAAAT-
CGCTCAAAGAGGAGATTGACATGGGATCCAG-
TGC (99)
4 GCACTGGATCCCATGTCAATCTCCTCTTTGAGC-
GATTTCATTGTACAATGATGAGCGTTAATTAA-
CTATTTATTAATTAGTTTGTAGAGAATTCTCG-
AC (99)
5C CTCGAGCTCATCATTGTACAATGAACTG (29)
6 TCCCAAGCTTCCTCAGACCAGATTAGTTTC (30)
7 TCCCAAGCTTAGATCTATAAGGCTACGCTA-
GC (32)
8 GCGATACATATGCGTACAATTAGCTACAGCG-
AA (33)
9G C CTCGAGATTAGTTTCACTCAATGATGTCC (31)
10 ATACTCGAGCTCAATGATGTCCTTTTCCGTT-
CC (33)
11 GGTTGCTCTTCCGCACTCAATGATGTCCTTTTCC-
GTTC (38)
12 CCACTCGAGTTCAATAATGATAACGACATGCT-
GC (34)
13 CCACTCGAGATAATGATAACGACATGCTGC (30)
14 CGCGGGAATTCGGGGAAAGGAGGGGG (26)
15 CGGTCGGATCCTGACGCGCTTCGCTG (26)
aRestriction enzyme recognition sites are underlined, and translation start and
stop codons are highlighted in bold.
Table 2. Plasmids used in this study
Plasmid Description Reference
pRS415 Vector for generating transcriptional fusion to lacZ (34)
pBAD33 Arabinose-inducible expression vector (35)
pET16b IPTG-inducible expression vector allowing fusion of a N-terminal His10 tag to a target protein Novagen
pET22b(+) IPTG-inducible expression vector allowing fusion of a C-terminal His6 tag to a target protein Novagen
pTYB1 IPTG-inducible expression vector allowing fusion of a bifunctional tag, consisting of an intein
and a chitin binding domain, to the C-terminus of a target protein
New England Biolabs
pRSyy_wt yefM-yoeB promoter-operator region cloned as annealed oligonucleotides 1/2 between BamHI
and EcoRI restriction sites of pRS415
This study
pRSyy_Smut yefM-yoeB promoter-operator region with mutagenized S repeat cloned as annealed
oligonucleotides 3/4 between BamHI and EcoRI restriction sites of pRS415
This study
pBADyefM yefM amplified with oligonucleotides 5/6, digested with XhoI–HindII and cloned between the
equivalent sites in pBAD33
This study
pBADyefMyoeB yefM-yoeB amplified with oligonucleotides 5/7, digested with XhoI–HindII and cloned between
the equivalent sites in pBAD33
This study
pET16yefM yefM amplified with oligonucleotides 8/9, digested with NdeI–XhoI and cloned between the
equivalent sites in pET16b
This study
pET22yefM yefM amplified with oligonucleotides 8/10, digested with NdeI–XhoI and cloned between the
equivalent sites in pET22b(+)
This study
pTYByefM yefM amplified with oligonucleotides 8/11, digested with NdeI–SapI and cloned between the
equivalent sites in pTYB1
This study
pET16yefMyoeB yefM-yoeB amplified with oligonucleotides 8/12, digested with NdeI–XhoI and cloned between
the equivalent sites in pET16b
This study
pET22yefMyoeB yefM-yoeB amplified with oligonucleotides 8/13, digested with NdeI–XhoI and cloned between
the equivalent sites in pET22b(+)
This study
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glycerol containing 3, 2 or 1 M urea, followed by buffer with-
out urea. The renatured YoeB sample was then dialysed again
for 16 h against buffer without urea, aliquoted and stored at
 80 C. For puriﬁcation of YoeB-His6, 300 ml of E.coli
BL21 harbouring a pET22b(+) plasmid producing YefM–
YoeB–His6 were grown at 37 C until OD600   0.8 and
subsequent steps followed the procedure described for puri-
ﬁcation of untagged YoeB with the following differences:
ﬁrst, buffer C contained 50 mM, instead of 100 mM, imida-
zole. Second, untagged YefM was denatured and eluted with
buffer D, followed by YoeB-His6 with buffer D that con-
tained 200 mM imidazole. YoeB-His6 was renatured by
dialysis into successively more dilute concentrations of urea
as described for untagged YoeB. Refolding of denatured
proteins was monitored by circular dichroism (CD).
Electrophoretic mobility shift assays (EMSA)
DNA substrates consisted of 50-biotinylated, double-stranded
oligonucleotides 1/2 (Table 1) that included the yefM start
codon and 74 bp of the yefM-yoeB regulatory region.
Oligonucleotides 3/4 consist of the same sequence, but with
mutations in the S repeat. Reactions containing 0.1 nM of
biotin-labelled DNA and the protein concentrations indicated
in the legend to Figure 2 were assembled in binding buffer
[10 mM Tris–HCl (pH 7.5), 50 mM NaCl, 1 mM DTT,
5 mM MgCl2,1mg of poly(dI·dC), 2.5% glycerol] in ﬁnal
volumes of 20 ml and incubated for 20 min at 22 C. For
YefM–YoeB reconstitution experiments, the two untagged
proteins were ﬁrst coincubated for 20 min prior to adding
DNA. Samples were electrophoresed on 6% native polyacryl-
amide gels in 0.5· TBE buffer for 90 min at 80 V at 22 C.
DNA was transferred by capillary action or electroblotting
topositively-chargednylonmembranes(Roche),andthetrans-
ferred DNA fragments were immobilized onto the membrane
by ultraviolet (UV) cross-linking. Detection of the biotin
end-labelled DNA was performed using the LightShift 
chemiluminescent EMSA kit (Pierce).
DNase I footprinting
220 bp PCR fragments in which either the top or bottom
strand was 50 biotinylated were generated with oligonu-
cleotides 14/15, and were electrophoresed on 7.5% polyacryl-
amide gels with 7.5% glycerol in 1· TBE buffer. Fragments
were excised from gels and electroeluted in 0.1· TBE for
30 min at 100 V. The DNA was extracted with phenol:chloro-
form (1:1) and precipitated with ethanol. DNA was harvested
by centrifugation, and the pellets dried and resuspended in
sterile water. Reactions containing 2 nM of biotin-labelled
DNA and YefM or YefM–YoeB–His6 protein at concentra-
tions indicated in the legend to Figure 3 were mixed in bind-
ing buffer [20 mM Tris–HCl (pH 7.5), 50 mM NaCl, 5 mM
MgCl2, 1 mM DTT, 5% glycerol, 1 mg of poly(dI·dC)
and 10 mg of BSA] in a ﬁnal volume of 20 ml and incubated
for 20 min at 22 C. Each reaction was treated with 0.0075 U
of DNase I (Roche, RNase free, 10 U/ml diluted in buffer
[20 mM Tris–HCl (pH 7.5), 50 mM NaCl, 7.5 mM MgCl2
and 5 mM CaCl2]) for 45 s at 22 C. Reactions were stopped
by addition of 200 ml of stop solution (10 mM EDTA and
300 mM sodium acetate) followed by extraction with an
equal volume of phenol:chloroform (1:1). The upper phase
was collected and 1 ml of glycogen (Roche) and 500 mlo f
ethanol were added. Samples were precipitated at  80 C
for 30 min, harvested by centrifugation, and the pellets
washed with 70% ethanol. Pellets were dried and resuspended
in 10 ml of loading buffer (95% formamide, 20 mM EDTA,
0.05% bromophenol blue and 0.05% xylene cyanol). Samples
were heated at 99 C for 10 min and loaded on 6% sequencing
gels (SequaGel; GeneFlow), which were pre-run for at least
100 min. Samples were electrophoresed at 60 W in 1· TBE
buffer for 2 h for fragments in which the bottom strand was
biotin-labelled, or for 3 h for fragments in which the top-
strand was biotin-labelled. DNA was transferred by capillary
action to positively-charged nylon membranes (Roche), and
the transferred DNA fragments were immobilized onto the
membrane by UV cross-linking. Detection of the biotin
end-labelled DNA was performed using the LightShift 
chemiluminescent EMSA kit (Pierce).
Maxam–Gilbert sequencing
A total of 30 nM of DNA was diluted in water to a ﬁnal vol-
ume of 12 ml, and 50 ml of formic acid was added. The sam-
ple was incubated for 2.5 min at 22 C; the reaction stopped
by adding 200 ml of 300 mM sodium acetate (pH 7.0) and
700 ml of ice-cold ethanol and precipitated for 15 min at
 80 C. The DNA was harvested by centrifugation for
15 min at 4 C. The pellet was washed three times with
70% ethanol, each time centrifuging for 10 min at 4 C and
discarding the supernatant. The pellet was dried, resuspended
in 100 ml of a 1 M solution of piperidine and incubated for
30 min at 90 C. A total of 10 ml of 3 M sodium acetate
(pH 7.0) and 300 ml of ice-cold ethanol were added and incu-
bated for 20 min at  80 C. The pellet was washed twice with
1 ml of 70% ethanol, dried and resuspended in 20 ml of load-
ing buffer. Sequencing reactions were analysed on 6%
sequencing gels alongside the corresponding DNase I foot-
printing reactions.
Primer extension analysis
Total cellular RNA from strain DH5a harbouring a pRS415-
based plasmid possessing a transcriptional fusion of the yefM-
yoeB promoter-operator region to the lac operon (pRSyy_wt),
and primer extension mapping were performed essentially as
described previously (36) using 50-biotinylated oligonu-
cleotide 15 (Table 1).
Assays of b-galactosidase activity
Strain SC301467 harbouring the pRS415 plasmid with a lacZ
gene under transcriptional control of the yefM-yoeB promoter
(pRSyy_wt), or with mutations in the S repeat (pRSyy_
Smut), was cotransformed with pBAD33 plasmids encoding
yefM or yefM-yoeB genes under control of an arabinose-
inducible promoter (pBADyefM and pBADyefMyoeB). At
OD600   0.2, synthesis of antitoxin or TA was induced by
addition of 0.2% arabinose for 1 h. b-Galactosidase assays
were performed with cells permeabilized with chloroform
and SDS as described by Miller (37). Plasmids pBADyefM
and pBADyefMyoeB were generated using oligonucleotides
5/6 and 5/7 in ampliﬁcation of the yefM and yefM-yoeB
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the equivalent sites in pBAD33. Oligonucleotides 1/2 and 3/4
were annealed, digested with EcoRI–BamHI and inserted in
pRS415 to produce pRSyy_wt and pRSyy_Smut, respectively.
CD spectroscopy
YefM or YefM–YoeB–His6 were buffer-exchanged using
Microcon 3 kDa cut off ﬁlters (Millipore) into 20 mM
Tris–HCl (pH 8.5), 50 mM NaCl. For CD, YefM and
YefM–YoeB–His6 were used at concentrations of 10 and
5 mM, respectively. 99 bp double-stranded oligonucleotides
1/2 and 3/4 were used at concentrations of 2 mM. CD scans
were performed in a Jasco J-810 spectropolarimeter at
20 nm/min with a 0.2 nm data pitch and 1 s response using
a 1 mm band width for eight accumulations at 20 C. Tem-
perature scans were performed at 222 nm, with a temperature
change of 1 C/min from 5 to 80 C. Following a 1 s rest inter-
val, reverse scans were performed at the same speed.
Nuclear magnetic resonance (NMR) spectroscopy
Proton NMR spectra of YefM were recorded at 30 Co na
Bruker Avance DRX 600 MHz spectrometer equipped with
a CryoProbe, in 50 mM Tris (pH 8.5), 150 mM NaCl in
95/5%
1H2O/
2H2O. Spectral data were processed using Top-
Spin (Bruker). Standard pulse sequences, with WATER-
GATE water suppression, were used.
Chemical cross-linking
Dimethyl pimelimidate (DMP) (Sigma) was added to reac-
tions at a ﬁnal concentration of 10 mM. Proteins were diluted
to 20 mM (YefM) or 14 mM (YefM–YoeB) in buffer [20 mM
HEPES-NaOH (pH 8.5), 50 mM NaCl and 5 mM MgCl2].
The ﬁnal reaction volume was 20 ml. Reactions were incu-
bated at 22 C as indicated in Figure 7, and stopped by the
addition of 1 ml of 0.5 M Tris–HCl (pH 6.8) followed by 2·
SDS loading buffer. The samples were heated at 95 C for
5 min and analysed by SDS–PAGE (15% polyacrylamide).
Hydrodynamic properties
Molecular mass and hydrodynamic radius of YefM were
determined using a combination of size exclusion chromatog-
raphy, multi-angle light scattering (MALS) and quasi-elastic
light scattering (QELS). YefM [in 10 mM Tris and 100 mM
NaCl (pH 8.5)] was applied to a Superdex 75 10/30 column
that had been pre-equilibrated in the same buffer, and eluted
at room temperature at a ﬂow rate of 0.710 ml/min. The col-
umn was attached downstream to a multiangle laser light
(690.0 nm) scattering DAWN EOS photometer (Wyatt).
QELS data were collected using a Wyatt-QELS instrument.
The concentration of the eluted protein was estimated using
values of 0.180 for the refractive index increment (dn/dc)
and 1.330 for the solvent for the solvent refractive index.
Molecular weights were determined using a Zimm plot.
Data were analysed using Astra 4.90.08 software (Wyatt) as
recommended by the manufacturer.
Bioinformatics
YefM–YoeB homologs were identiﬁed in the National Center
for Biotechnology Information (NCBI) database using PSI- and
PHI-BLAST searches (38). The nucleotide sequences of the
regions upstream of the corresponding genes were aligned
using ClustalW (39). GlobPlot (40) was used to predict intrin-
sic disorder in YefM.
RESULTS
YefM and YoeB are the transcriptional repressor and
corepressor, respectively, of the yefM-yoeB genes
During in vitro transcriptional analysis of the histidine
biosynthesis (his) genes in E.coli K-12, a cryptic transcript
was detected from a promoter orientated divergently to the
his operon promoter (41,42). In hindsight, this transcript is
likely to be derived from the recently identiﬁed yefM-yoeB
cassette, which is located upstream of the his genes, but
which apparently is transcribed in the opposite direction
(19). Sequencing of the in vitro transcript mapped its 50 end
to position -3 of the yefM-yoeB promoter region illustrated in
Figure 1A (41). However, primer extension analysis per-
formed here unambiguously delineated the in vivo transcrip-
tion start point to a position three nucleotides 30 of that
previously assessed (Figure 1B). Sequences with close
matches to consensus  10 and  35 hexamer promoter
boxes, and which are separated by an optimal 17 bp, are
located 50 of this transcription start point (Figure 1A). The
discrepancy between the primer extension analysis here and
previous transcript sequencing experiments might reﬂect dif-
ferences in transcription start site selectivity in vivo and
in vitro,o r5 0 end processing of the in vivo transcript which is
absent in vitro. Nevertheless, both datasets strongly indicate
that the ﬁrst position in the yefM translational start codon is
at position +21, and not at another potential start codon at
 7 as suggested previously (24) (Figure 1A). The region 50
of position +21 also possesses a sequence that resembles a
ribosome binding site separated by a window of 6 bp from
the putative yefM ATG initiation codon. These observations
agree with ﬁndings that overexpressed yefM which includes
the potential start codon at  7t o 5 produces a translation
product that commences at position +21 (21).
A 99 bp fragment encompassing the yefM-yoeB promoter
and yefM start codon was inserted upstream of a promoterless
lac operon in the transcription fusion vector pRS415. This
fusion produced 4099 ± 547 U of b-galactosidase activity
in strain SC301467, which is deleted of chromosomal yefM-
yoeB genes (22), whereas pRS415 alone produced <100 units.
Thus, the region 50 of yefM-yoeB possesses substantial pro-
moter activity. Subsequently, YefM protein was provided in
trans from an arabinose-inducible promoter, and its effect
on b-galactosidase production by the yefM–lacZ fusion was
examined: b-galactosidase levels were reduced  5.5-fold to
739 ± 164 U in the presence of YefM (Figure 1C). Moreover,
coexpression of yefM-yoeB in trans further reduced b-
galacosidase levels to background levels (126 ± 33 U).
Thus, YefM is a transcriptional autorepressor of the yefM-
yoeB promoter, with YoeB acting as a corepressor.
YefM and YefM–YoeB recognize DNA palindromes
with common core sequences
Three versions of YefM were puriﬁed to >95% homogen-
eity and tested in EMSA with a 99 bp double-stranded
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moter region: native YefM isolated following cleavage from
a fusion of the C-terminus of the protein to the N-terminus
of an intein tag; YefM with a hexahistidine tag at its
C-terminus (YefM-His6); and YefM with a 21 amino acid
extension, including a decahistidine tag, at its N-terminus
(His10-YefM). Native YefM weakly bound the 99 bp oligonu-
cleotide, producing a single-retarded complex in EMSA
(Figure 2A). Although complex formation apparently was
inefﬁcient, the interaction of YefM with the yefM-yoeB pro-
moter region was speciﬁc as no retarded species were
observed in EMSA with an unrelated substrate. Similar
DNA binding patterns were observed with YefM-His6 (data
not shown) indicating that the C-terminal tag does not
detectably impede interaction of YefM with DNA. In contrast,
His10-YefM produced a smear of higher molecular weight
complexes with the 99 bp oligonucleotide suggesting that
the N-terminal tag signiﬁcantly altered the association of
YefM with DNA (data not shown). This observation correlates
with the suggestion that a conserved basic patch in the
N-terminal domain of YefM might be involved in DNA
recognition (21).
The 30 end of yefM overlaps the 50 of yoeB by 1 bp. These
overlapping genes were cloned in an expression vector to per-
mit puriﬁcation of a YefM–YoeB–His6 complex in which
the two proteins are present at a physiological ratio. The
YefM-YoeB-His6 complex produced a major retarded species
at >200-fold lower protein concentrations than that generated
by YefM alone (Figure 2B). Furthermore, at YefM–YoeB
concentrations >12 nM, >90% of the substrate was bound
into nucleoprotein complex(es), in contrast with YefM
alone which retarded <1% of the substrate at this concentra-
tion. The nucleoprotein complex formed by YefM–YoeB–
His6 migrated slightly more slowly in EMSA than that
produced by YefM suggesting that the former incorporates
a greater number of protein protomers than the latter and/or
that the conformation of the DNA in the complexes differ.
YoeB protein was puriﬁed as a hexahistidine-tagged
(YoeB–His6) version from the YefM–YoeB–His6 complex,
as well as in native form from the His10–YefM–YoeB com-
plex. Neither version of YoeB generated a shifted complex
with the yefM-yoeB promoter DNA in EMSA revealing that
the protein apparently does not bind directly to DNA
(Figure 2C). Mixing experiments in which native, untagged
YefM and YoeB were preincubated in different ratios and
subsequently used in binding experiments with the 99 bp
double-stranded oligonucleotide showed that the reconsti-
tuted YefM–YoeB complex produced a major retarded spe-
cies with migration analogous to that observed with the
YefM–YoeB–His6 complex. Thus, co-puriﬁed and recon-
structed YefM–YoeB complexes exhibit similar DNA bind-
ing properties. Finally, the optimal YefM:YoeB ratio at
Figure 1. Autoregulation of the yefM-yoeB module. (A) Nucleotide sequence of the region 50 of yefM-yoeB. The transcription start-site mapped by primer
extension is marked as +1. Hexameric promoter motifs are boxed and the yefM start codon is in bold. The 50 end of the yefM-yoeB transcript previously
determined by RNA sequencing (41,42) is indicated by the filled circle. Long (L) and short (S) palindromes recognized by YefM-YoeB are denoted by inverted
arrows. (B) Primer extension analysis of the yefM-yoeB module. Total RNA from E.coli DH5a harbouring a plasmid possessing the yefM-yoeB operon was
subjected to primer extension analysis (E) using a 50-biotinylated primer that anneals within flanking vector sequences. Reactions were performed and analysed
as outlined in Materials and Methods, and electrophoresed on a denaturing 6% polyacrylamide gel in parallel with nucleotide sequencing reactions (A,C ,G ,T )
carried out with the same biotinylated primer. The major product from the primer extension is marked as +1. (C) Autoregulation of yefM-yoeB expression by
YefM and YefM-YoeB. A transcriptional fusion of the yefM-yoeB regulatory region to the lacZYA operon in plasmid pRS415 (pRSyy_wt) was transformed into
E.coli SC301467, which is deleted of five chromosomal TA cassettes including yefM-yoeB, and b-galactosidase levels determined without YefM, and with YefM
(pBADyefM) or YefM-YoeB (pBADyefMyoeB) supplied in trans from the pBAD33 arabinose-inducible vector (filled columns). Similar experiments were
performed with a transcriptional fusion in which the S palindrome was mutated (pRSyy_Smut) (open columns).
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and 2:1 (Figure 2C). This correlates with biophysical and
structural studies which demonstrated that puriﬁed YefM–
YoeB complex consisted of either a 1:2 or 2:1 mix of the
two proteins (21,24).
The binding sites for YefM and YefM–YoeB–His6 in the
yefM-yoeB promoter region were localized by DNase I foot-
printing (Figure 3). YefM ﬁrst speciﬁcally protected the
region between  17 and  3 on the upper strand from
DNase I digestion, with an extended footprint between
 2 and +12 at higher protein concentrations. Protection of
the bottom strand was staggered by 3 or 4 nt in the
30 direction with protection initially occurring from  21 to
 6 and then between  5 and +8. The observed 30-stagger
potentially reﬂects minor groove coverage at these ends
(43). Position  14 on the lower strand is hypersensitive to
DNase I cleavage in the presence of YefM indicating that
the DNA structure is perturbed at this point. The extent of
protection on both strands by the YefM–YoeB–His6 complex
was indistinguisable from that provided by YefM alone at
higher protein concentration. However, protection against
DNase I digestion by YefM–YoeB-His6 occurred at  100-
fold lower protein concentration than by YefM, assuming a
2:1 ratio of YefM:YoeB. In addition, the enhancement at
position  14 on the bottom strand was more pronounced in
the presence of YefM–YoeB–His6 (Figure 3). The DNase I
footprinting results agree with EMSA data demonstrating
that the yefM-yoeB promoter region is bound more avidly
by the two-protein complex than by YefM alone.
The YefM and YefM–YoeB–His6 DNase I footprints cover
the  10 hexamer promoter box as well as 30 and 50 ﬂanking
regions, suggesting that the proteins inhibit transcription by
blocking the access of RNA polymerase to the yefM-yoeB
promoter (44). The primary region protected by YefM against
DNase I attack includes a 50-TCATTGTACAATGA-30 palin-
drome (L [long] repeat). The 50-TGTACA-30 core of this
inverted repeat is also present in the secondary region of
YefM protection (S [short] repeat) (Figure 3). Preferential
binding of YefM to the L repeat might be facilitated by the
additional palindromic nucleotides that ﬂank the hexameric
core sequence within this repeat, but that are absent from
the S repeat. In summary, the operator site for yefM-yoeB
autoregulation encompasses a pair of palindromic sequences
that possess a common 50-TGTACA-30 core with a centre-to-
centre distance of 12 bp.
The S repeat plays a crucial role in transcriptional
repression and DNA binding by YefM–YoeB
Multiple substitution mutations were introduced into the S
repeat in the operator site (Figure 2D) to assess the contribu-
tion of this motif to regulation of yefM-yoeB expression. Dis-
ruption of the S repeat did not detectably perturb either
unregulated expression from the resulting yefM(S0)-lacZ
fusion or repression of this fusion by YefM in vivo
(Figure 1C). However, the YefM–YoeB complex failed to
exert additional downregulation of the yefM(S0)-lacZ fusion,
which was observed with the wild-type yefM–lacZ fusion.
Indeed, YefM–YoeB reproducibly repressed the yefM(S0)–
lacZ fusion slightly less efﬁciently than did YefM alone.
Interactions between YefM–YoeB complexes assembled at
Figure 2. YefM and YefM-YoeB binding to the yefM-yoeB promoter-
operator region. (A) A 99 bp double-stranded oligonucleotide (0.1 nM) that
was 50 biotinylated on one strand and that included the yefM translation start
codon and 74 bp upstream was subjected to EMSA using increasing amounts
of native YefM. YefM concentrations used (left to right) (mM): 0, 0.032,
0.064, 0.125, 0.25, 0.5, 1.0, 2.0, 4.0 and 8.0. Reactions were processed as
outlined in Materials and Methods. Open and filled arrows denote positions
of unbound oligonucleotide and YefM–DNA complexes, respectively. (B)
EMSA of the same biotinylated oligonucleotide as in (A) using increasing
amounts of YefM–YoeB–His6. Protein concentrations used (left to right)
(mM): 0, 0.003, 0.006, 0.012, 0.024, 0.048, 0.1, 0.2, 0.4 and 0.8. Open and
filled arrows denote positions of unbound oligonucleotide and YefM–YoeB–
His6–DNA complexes, respectively. (C) EMSA of the same biotinylated
oligonucleotide as in (A) with YefM–YoeB reconstituted from individual
native proteins. The first three lanes contained no protein, YefM only (1 mM)
or YoeB only (1 mM). The following lanes contained YoeB (1 mM) and
increasing concentrations of YefM (mM): 0.125, 0.250, 0.5, 1.0, 2.0, 4.0 and
8.0. Open and filled arrows denote positions of unbound oligonucleotide and
YefM–YoeB–DNA complexes, respectively. (D) Top, nucleotide sequence of
the yefM-yoeB promoter–operator region with substitution mutations (stars)
that disrupt the S palindrome. Bottom, EMSA of a 99 bp oligonucleotide
substrate harbouring the S palindrome mutations without added protein, with
native YefM (8 mM) and with YefM–YoeB–His6 (6 mM).
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tion of the S palindrome that cooperativity is weakened
resulting in reduced binding of the complex to the palin-
dromes. In accord with the in vivo results, both the weak
binding by YefM and the more proﬁcient interaction of
YefM–YoeB–His6 with a substrate encompassing the yefM-
yoeB promoter region in vitro were abolished with an analo-
gous 99 bp double-stranded oligonucleotide harbouring the S
repeat mutations (Figure 2D). In combination, these results
emphasize that the S repeat is critical for association of the
YefM–YoeB complex with the yefM-yoeB operator site,
and that its disruption dramatically impairs the interaction
of the protein complex with the site.
YefM possesses extensive secondary structure
CD analysis suggested that YefM is an unfolded protein that
entirely lacks secondary structure (24). However, native
YefM puriﬁed here exhibited distinct CD minima at  208
and  222 nm that are characteristic of a-helix content and
helix–helix interactions, respectively, and which indicate
that the protein was at least partly folded (Figure 4A).
The relatively shallow peak at 222 nm in comparison with
the deeper trough at 208 nm implies that the protein lacks
extensive coiled-coil formation (45). Deconvolution of the
data with CDSSTR software (46) suggested that the a-helical
helical content of YefM was  40%, with  30% b-strands,
5–10% turns, and the remainder unordered. Analogous
results were obtained with His10-YefM (data not shown).
The recently-described tertiary structure of the YefM–YoeB
heterotrimeric complex consists of one YoeB monomer
associated with a YefM homodimer. The YefM homodimer
is asymmetric with one of the YefM monomers possessing a
disordered C-terminal region, whereas the equivalent region
of the second monomer is folded (21). The a-helical content
of the asymmetric YefM homodimer within the complex
was 45%, with 20% b-strands, 18% turns and 17% disor-
dered: these values are not dissimilar to those obtained
from CD studies of YefM here. In the absence of high-
resolution information about the tertiary structure of free
YefM, it remains to be clariﬁed whether YefM undergoes
structural transitions between its free state and when associ-
ated with YoeB, although this seems likely.
In view of the inconsistency between the CD spectra
for YefM observed here (Figure 4A) and those described
recently (24), NMR spectra were acquired to provide another
Figure 3. DNase I footprinting of the yefM-yoeB promoter-operator region. Footprinting reactions were performed as outlined in Materials and Methods using
PCR fragments biotinylated at the 50 ends of either upper or lower strands. YefM concentrations (mM, left to right): 0, 0.01, 0.025, 0.05, 0.1, 0.25, 0.5, 1.0, 2.5 and
5.0. YefM–YoeB–His6 concentrations (mM, left to right): 0, 0.007, 0.018, 0.036, 0.072, 0.18, 0.36, 0.72, 1.8 and 3.6. The locations of the L and S repeats are
marked by inverted arrows. Shaded boxes denote the regions protected from DNase I digestion by YefM and YefM–YoeB–His6.A+ G, Maxam–Gilbert
sequencing reactions. A position on the lower strand that is hypersenstive to DNase I cleavage in the presence of YefM and YefM–YoeB–His6 is highlighted by
the star. The relative dispositions of regions on the upper and lower strands that are protected from DNase I digestion and other features of the yefM-yoeB
promoter–operator region are illustrated in the lower panel.
332 Nucleic Acids Research, 2007, Vol. 35, No. 1assessment of the protein’s conformational state. The 1D
spectrum of YefM-His6 is shown in Figure 5 and the 2D
NOESY in Figure 6. Close examination of the spectra reveals
a mixture of resonances in which well-dispersed signals are
superimposed upon resonances that are clustered together;
these characteristics are clearly seen in the amide and methyl
proton regions (Figure 5). In addition, resonances are also
observed in the region just downﬁeld of the water resonance,
these being typically from residues in b-strands. The 2D
NOESY spectra showed cross-peaks which are indicative of
secondary structures: cross-peaks between amide protons
suggest the presence of helices, cross peaks between amide
Figure 4. CD analysis of the YefM and YefM–YoeB–His6 proteins in the absence and presence of DNA. (A) Far UV CD spectrum of YefM alone (10 mM), and
in the presence of 2 mM 99 bp oligonucleotides with the yefM-yoeB promoter–operator region, the same region but with mutations in the S palindrome
(Figure 2D), and without the promoter–operator sequences. Spectra of complexes are difference spectra as any contribution of the oligonucleotides to the spectra
is subtracted from the spectrum of the complex. (B) Far UV CD spectrum of YefM–YoeB–His6 alone (5 mM), and in the presence of 99 bp oligonucleotides with
the yefM-yoeB promoter–operator region, the same region but with mutations in the S palindrome (Figure 2D), and without the promoter–operator sequences.
(C) Thermal denaturation of native YefM (10 mM) monitored by CD at 222 nm. Denaturation of YefM was followed from 5–80 C (black line). YefM
renaturation was subsequently analysed (red line). (D) Far UV spectra of native YefM (20 mM) before (black line) and after (red line) thermal denaturation.
Figure 5. The 1D proton spectrum of YefM (150 mM) in 50 mM Tris (pH 8.5), 150 mM NaCl at 30 C. Regions of resolved methyl and amide resonances are
highlighted.
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indicate the presence of b-strands. The NOESY peaks
between the upﬁeld methyl protons and downﬁeld amide
and aromatic protons additionally suggest the presence of ter-
tiary structures. Therefore, the NMR data show that the
recombinant YefM-His6 used in the present studies has sec-
ondary and tertiary structures. A series of spectra were col-
lected at increasing temperatures from 15 to 30 C. Apart
from systematic shifts due to temperature variation and a gen-
eral decreased in linewidths resulting from the faster tum-
bling of the protein in solution at higher temparatures, the
spectra of YefM-His6 remained essentially the same, with lit-
tle signs of thermal unfolding; this is further evidence that
YefM-His6 adopts a somewhat stable conformation within
this temperature range. Overall, the NMR data suggests that
the YefM protein exists either as a mixture of folded and
unfolded states, or that the protein has folded and unfolded
regions in its tertiary structure.
Further investigations into these options were carried out
using CD by examination of the temperature dependence of
ellipticity at 222 nm in 0.2 C steps over the range 5–80 C
at a heating rate of 1 C/min (Figure 4C). The protein showed
a gradual melting transition and dimunition of the CD signal
indicating a non-cooperative unfolding process, again reﬂec-
tive either of a mobile, partially unfolded protein and/or that
YefM exists in a variety of folded states. The midpoint of the
denaturation curve revealed a melting temperature (Tm)o f
 45 C. No visible precipitation of the protein sample was
apparent at 80 C. When the sample was cooled gradually
to 5 C and monitored by CD ellipticity at 222 nm, a pattern
very similar in reverse to that of the denaturation proﬁle
was observed (Figure 4C). Moreover, the CD spectra of
native and renatured YefM were virtually indistinguishable
indicating that heat denaturation of native YefM is fully
reversible (Figure 4D). The CD spectrum of YefM–YoeB–
His6 observed here (Figure 4B) is similar to that described
previously (20), as is the complex’s thermal denaturation
curve over the range 5–80 C which conﬁrms a pronounced
Tm at  60 C, and lack of renaturation following heating to
80 C (data not shown).
CD spectra in the near- and far-UV regions can be used to
discriminate between DNA and protein within a nucleopro-
tein complex as the far UV region of the spectrum is domi-
nated by contributions of amide moieties from the peptide
backbone, whereas secondary structure alterations in nucleic
acids upon formation of the nucleoprotein complex are evi-
dent in the non-overlapping region from 240 to 320 nm.
This distinction was used to assess whether YefM or YefM-
YoeB-His6 underwent detectable structural changes when
bound to operator DNA, and vice versa. To allow comparison
of protein spectra free and in the DNA bound state, the con-
tribution of the DNA was subtracted from the curves. Con-
versely, any contribution of the protein in the 240–320 nm
region was subtracted separately to allow assessment of spec-
tral alterations indicative of changes in DNA when com-
plexed with protein. Using a 5:1 molar concentration of
YefM and a 99 bp DNA fragment encompassing the operator
site, the CD minima at 208 and 222 nm became more pro-
nounced than in the absence of DNA (Figure 4A). An equiva-
lent DNA fragment harbouring mutations in the S repeat
(Figure 2D) induced less profound alterations in the far UV
region, whereas YefM spectra in the presence and absence
of a DNA fragment without a YefM recognition site were
indistinguishable. The results suggest that YefM undergoes
structural transitions when bound to DNA, and that the alter-
ations are induced speciﬁcally by its cognate binding site.
Analogous CD results were noted for YefM-YoeB-His6 in
the absence and presence of the three different DNA frag-
ments, except that the fragment containing S repeat mutations
elicited a weaker response with YefM-YoeB-His6 than with
YefM (Figure 4B).
B-form DNA presents a typical positive CD maximum
centred at 275 nm, a minimum near 245 nm, with a zero
point transition around 258 nm (47). The yefM-yoeB opera-
tor DNA showed no signiﬁcant alterations in these charac-
teristics in the presence YefM or YefM-YoeB-His6 (data
not shown), suggesting that the operator site does not under-
go major structural transitions when bound by its cognate
proteins.
YefM is dimeric in solution
Cross-linking experiments with DMP were performed to
characterize the oligomeric state of native YefM (9.3 kDa).
Figure 6. A section of the 600 MHz 2D
1H-
1H NOESY spectrum (tm 100 ms)
of YefM (150 mM) in 50 mM Tris (pH 8.5), 150 mM NaCl at 30 C. Regions
containing cross peaks from regular secondary and tertiary structures are
shown: (A) NH-NH, (B) NH-aH and (C) aromatic/NH-methyl protons.
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cular mass of a dimer was frequently evident in untreated
samples analysed by SDS–PAGE. Moreover, a signiﬁcant
fraction of YefM was rapidly ﬁxed into covalently bound
dimers with 10 mM DMP at 22 C (Figure 7A). Similar results
were noted with DMP concentrations as low as 0.1 mM
(data not shown). These results demonstrate that YefM
forms dimers in solution. In the case of YefM-YoeB-His6
(29.9 kDa), DMP cross-linking produced a  22 kDa species
that is likely to be dimeric YefM, and a doublet at  30 kDa
that correlates with a trimeric YefM–YoeB–His6 complex
(Figure 7B), as noted previously (20,21).
YefM eluted predominantly (>98%) as a single peak in size
exclusion chromatography on a Superdex 75 10/30 column.
MALS of this peak material was consistent with the presence
of a major dimeric species: the molecular weight distribution
across the peak area was 19.70 ± 0.79 kDa (Figure 7C). Thus,
both cross-linking and MALS studies conclusively demon-
strated that YefM is a dimer in solution. Moreover, the hydro-
dynamic radius of native YefM determined by QELS
performed in parallel with MALS was 2.6 nm (Figure 7C).
This is relatively elongated for a molecule of this size
suggesting that unstructured regions might contribute to the
protein’s extended conformation, in agreement with CD
(Figure 4) and NMR (Figures 5 and 6) results.
Paired L and S palindromes in yefM-yoeB
regulatory regions in diverse genomes
Homologues of yefM-yoeB are widely disseminated in bacte-
ria (19). To assess whether L and S palindromes might also
be implicated in transcriptional autoregulation of these homo-
logues, the regions upstream of the cassettes in diverse
genomes were scrutinized for the presence of 50-TGTACA-
30 motifs with a centre-to-centre distance of 12 bp, as in
E.coli K-12. Many yefM-yoeB genes were accompanied by
paired 50-TGTACA-30 boxes within 80 bp of the yefM trans-
lational start codon (Figure 8). Palindromicity in the more 50
motif often extended beyond the core hexamer sequence,
analogous to the L repeat in strain K-12. Although the paired
hexamer boxes were consistently separated by 6 bp, the
sequences of the spacers were relatively diverse, as were
both the sequences between the S repeat and the translational
start, and 50 of the L repeat. Although paired L and S palin-
dromes are embedded within the regulatory regions of numer-
ous yefM-yoeB operons, many of the genomes that were
analysed did not harbor 50-TGTACA-30 motifs upstream of
their yefM-yoeB genes suggesting that YefM–YoeB com-
plexes in these bacteria recognize different regulatory motifs,
or that regulation occurs by mechanisms that do not involve
YefM–YoeB.
Figure 7. Analysis of the solution oligomeric state of YefM. (A) Timecourse (minutes) of YefM cross-linking performed at 22 C in the presence of DMP
(10 mM). Samples were electrophoresed on a 15% SDS–polyacrylamide gel. Different species formed are indicated by arrows (right) and molecular marker
weights are expressed in kDa (left). (B) Timecourse (minutes) of YefM–YoeB–His6 cross-linking performed at 22 C in the presence of DMP (10 mM). Samples
were electrophoresed on a 15% SDS–polyacrylamide gel. Different species formed are indicated by arrows (right) and molecular marker weights are expressed in
kDa (left). (C) Molar mass distribution of YefM. Bottom, the solid line is the trace from the refractive index indicator. Peak area selected for analysis is between
the two dashed lines. Dots within the peak area are the weight average molecular weights for each slice, i.e. measured every second. Top, hydrodynamic radius
(nm) versus volume (ml) across the peak.
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The toxin components of TA systems are intracellular
molecular time bombs whose release from complexes with
their cognate antitoxins can trigger bacterial programmed
cell death or cell cycle arrest (7). Understanding the mecha-
nisms by which expression and activation of these toxins are
controlled could allow the development of artiﬁcial means
for toxin detonation, and therefore novel antibacterial strat-
egies. For example, chemical genetics approaches may reveal
innovativeantibiosis strategies based on small molecule per-
turbation of TA module expression. Among chromosomal
TA operons that have been analysed in E.coli, transcriptional
autoregulation has been demonstrated for the relBE and
mazEF modules. In both cases, the antitoxin acts as the prim-
ary repressor and the toxin as a co-repressor (27,28), which
are also features of plasmid TA complexes. The chromosomal
chpBI-chpBK TA operon is also autoregulated (48). Among
chromosomal systems, regulation of the mazEF operon has
been examined most closely: repression involves binding of
the MazE antitoxin–MazF toxin complex to two alternating
palindromes that overlap a pair of promoters that drive
mazEF expression. Factor for inversion stimulation (FIS)
weakly activates mazEF by interacting with sequences 50 of
the palindromes (30). In comparison, the yefM-yoeB operator
site consists of L and S palindromes that possess a common
hexameric core motif. The YefM antitoxin is the major tran-
scriptional autoregulator of the operon, preferentially recog-
nizing the L palindrome followed by the S repeat at
elevated protein concentrations in vitro. Dimerization of
YefM (Figure 7) probably reﬂects its interaction with these
palindromic DNA sites, and suggests that the YefM2–YoeB
heterotrimer observed in crystallographic studies (21) is
more likely to represent the repressor–corepressor complex
for transcriptional regulation than the YefM–YoeB2 complex
that has also been described (20).
YoeB is a corepressor that permits improved, probably
cooperative, DNA binding by YefM most likely by either
enhancing the stability of YefM, by altering YefM conforma-
tion to one that is more favourable for DNA binding, and/or
by stabilizing the nucleoprotein complex at the operator
site. Enhanced operator site binding by antitoxin when
complexed with cognate toxin is a general characteristic of
TA complexes. Furthermore, the binding of YefM alone or
YefM–YoeB to DNA induces structural alterations in the pro-
teins: examination of the far UV region in CD spectra
revealed alterations in molar ellipticity of the proteins within
the nucleoprotein complex. Although CD analysis suggests
that the operator site does not undergo major structural tran-
sitions when bound to either protein, the presence of a DNase
I hypersensitive cleavage site in the YefM- and YefM–YoeB-
operator complexes nevertheless suggests that the operator
site within the nucleoprotein complex undergoes deforma-
tions. DNA conformational changes such as bending, major
groove opening and kinking are not uncommon in repressor–
operator interactions (49–52), and reﬂect the formation of
DNA structures that interfere with assembly or progression
of the transcriptional machinery.
Bacteriophage P1 speciﬁes a TA complex comprised of the
Doc toxin and Phd antitoxin. Phd is the primary transcrip-
tional repressor of the phd-doc operon, with Doc acting as
a corepressor. The phd-doc operator site consists of two
8 bp palindromes that are 13 bp apart, centre to centre. The
palindromes are bound sequentially, each by one Phd
dimer, with Doc acting to promote cooperative binding of
Phd to the sites by an undeﬁned mechanism (26,28,53).
YefM and Phd are homologues, although Doc and YoeB
Figure 8. Paired 50-TGTACA-30 motifs in the promoter regions of yefM-yoeB operons from diverse bacteria. Sequences are aligned at the ATG start codons of
the yefM homologues. Paired 50-TGTACA-30 motifs, or motifs that possess no more than one mismatch, and that are separated by centre-to-centre distances of
12 bp are boxed. In one case, the spacing is 18 bp.
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Phd include core 50-GTAC-30 motifs (33), identical to the
central tetranucleotides of the L and S repeats recognized
by YefM (Figure 3). Furthermore, the N-terminal end of
Phd is required for DNA binding (33), which has also been
proposed to be the case for YefM (21). The interesting paral-
lels in operator organization, and apparently in the operator-
binding properties of the N-terminal regions of YefM and
Phd, attest to their common evolutionary origin. In contrast,
the C-terminal halves of the two proteins are implicated in
interactions with their cognate toxins and share very little
similarity (21,33,54), which has been proposed to reﬂect
modular exchange of DNA binding and toxin recognition
domains among proteins related to Phd (54), including
YefM homologues.
Equidistantly-spaced L and S repeats are common features
in the yefM-yoeB regulatory regions of numerous genomes
suggesting that YefM–YoeB homologues in diverse back-
grounds exert transcriptional regulation by a common mecha-
nism. Axe–Txe are YefM–YoeB homologues encoded by the
pRUM multiresistance plasmid of Enterococcus faecium (19).
L and S palindromes are located 50 of axe-txe (Figure 8).
However, the YefM homologue Axe does not repress the
yefM-yoeB promoter in vivo. Conversely, YefM fails to down-
regulate expression from the axe promoter (B. K˛ edzierska
and F. Hayes, unpublished data). Despite the speciﬁcity
observed in vivo, YefM and Axe recognize the non-cognate
operator sites in vitro with approximately equal afﬁnities
(B. K˛ edzierska and F. Hayes, unpublished data). Although
sequences that ﬂank the palindromes likely inﬂuence the
binding of YefM–YoeB to the repeats (Figure 7), additional
factors, e.g. architectural proteins might also be signiﬁcant
for repression of certain yefM-yoeB promoters in vivo, albeit
not for other promoters. Many genomes that do not possess
identiﬁable L and S repeats upstream of yefM-yoeB neverthe-
less harbour the 50-GTAC-30 tetranucleotides, which are
located at the centres of the L and S palindromes, and are
separated by 11–13 bp (data not shown). These abbreviated
repeats might represent minimal binding sites for the
cognate YefM–YoeB proteins. In contrast, other yefM-yoeB
homologues possess no upstream motifs that are obviously
related to L and S palindromes: the mechanism of regulation
of these yefM-yoeB operons remains to be investigated.
Based on CD analysis, YefM has been described as an
intrinsically unfolded protein that typiﬁes a novel family of
proteins that entirely lack any secondary structure (24). In
contrast, native YefM examined here is dimeric and exhibits
a CD spectrum that is consistent with a protein that is rela-
tively well-folded and which possesses extensive a-helix
and b-sheet features. This contention is supported by NMR
spectra of YefM, which display signatures characteristic of
a well-ordered protein containing both a-helical and b-strand
secondary structure. Prediction software tools for disordered
regions within proteins also suggest that YefM is well-
structured, with only a patch of amino acids close to the
C-terminus expected to be unfolded (Figure 9). CD analysis
of the Axe homologue of YefM shows that it is also highly-
structured (B. K˛ edzierska and F. Hayes, unpublished data).
It is also worth emphasizing that the YefM dimer within
the YefM2–YoeB complex is largely structured, possessing
a-helix, b-sheet and random coil elements with only the
C-terminal region of one YefM monomer (corresponding to
 18% of YefM2) being disordered (21). Moreover, the bulk
of the antitoxin dimer within the YefM2–YoeB complex pro-
jects tens of angstro ¨ms from YoeB and is highly organized. It
is difﬁcult to envisage how YefM might achieve dimerization
and become extensively structured principally by the interac-
tion of a single a-helix at the C-terminal end of one YefM
monomer with YoeB. Structure determination of free
YefM2, and of YefM and YefM-YoeB structures bound to
DNA, will provide further crucial insights into the mecha-
nism by which YefM–YoeB exerts transcriptional regulation.
ACKNOWLEDGEMENTS
The authors thank Laurence Van Melderen for providing
strain SC301467, and the Biomolecular Analysis Facility,
University of Manchester for assistance with MALS/QELS
analysis. This work was supported by a grant from The
Wellcome Trust to F.H. Funding to pay the Open Access
publication charges for this article was provided by a
Wellcome Trust Value in People Award to The University
of Manchester.
Conflict of interest statement. None declared.
REFERENCES
1. Potts,M. (2001) Desiccation tolerance: a simple process? Trends
Microbiol., 9, 553–559.
2. Chang,D.E., Smalley,D.J., Tucker,D.L., Leatham,M.P., Norris,W.E.,
Stevenson,S.J., Anderson,A.B., Grissom,J.E., Laux,D.C., Cohen,P.S.
et al. (2004) Carbon nutrition of Escherichia coli in the mouse
intestine. Proc. Natl Acad. Sci. USA, 101, 7427–7432.
3. Nystrom,T. (2004) Stationary-phase physiology. Annu. Rev. Microbiol.,
58, 161–181.
4. Shapiro,J.A. (1998) Thinking about bacterial populations as
multicellular organisms. Annu. Rev. Microbiol., 52, 81–104.
5. Hall-Stoodley,L., Costerton,J.W. and Stoodley,P. (2004) Bacterial
biofilms: from the natural environment to infectious diseases.
Nature Rev. Microbiol., 2, 95–108.
6. Camilli,A. and Bassler,B.L. (2006) Bacterial small-molecule signaling
pathways. Science, 311, 1113–1116.
Figure 9. GlobPlot prediction (40) of intrinsic disorder in YefM. Descending
regions correspond to putative domains, whereas the ascending region
between residues  70–80 is predicted to be disordered.
Nucleic Acids Research, 2007, Vol. 35, No. 1 3377. Hayes,F. (2003) Toxins-antitoxins: plasmid maintenance, programmed
cell death, and cell cycle arrest. Science, 301, 1496–1499.
8. Anantharaman,V. and Aravind,L. (2003) New connections in the
prokaryotic toxin-antitoxin network: relationship with the eukaryotic
nonsense-mediated RNA decay system. Genome Biol., 4, R81.
9. Pandey,D.P. and Gerdes,K. (2005) Toxin-antitoxin loci are highly
abundant in free-living but lost from host-associated prokaryotes.
Nucleic Acids Res., 33, 966–976.
10. Engelberg-Kulka,H. and Glaser,G. (1999) Addiction modules and
programmed cell death and antideath in bacterial cultures. Annu. Rev.
Microbiol., 53, 43–70.
11. Hazan,R., Sat,B. and Engelberg-Kulka,H. (2004) Escherichia coli
mazEF-mediated cell death is triggered by various stressful conditions.
J. Bacteriol., 186, 3663–3669.
12. Pedersen,K., Zavialov,A.V., Pavlov,M.Y., Elf,J., Gerdes,K. and
Ehrenberg,M. (2003) The bacterial toxin RelE displays codon-specific
cleavage of mRNAs in the ribosomal A site. Cell, 112, 131–140.
13. Christensen,S.K., Mikkelsen,M., Pedersen,K. and Gerdes,K. (2001)
RelE, a global inhibitor of translation, is activated during nutritional
stress. Proc. Natl Acad. Sci. USA, 98, 14328–14333.
14. Engelberg-Kulka,H., Sat,B., Reches,M., Amitai,S. and Hazan,R. (2004)
Bacterial programmed cell death systems as targets for antibiotics.
Trends Microbiol., 12, 66–71.
15. Zhang,Y., Zhang,J., Hara,H., Kato,I. and Inouye,M. (2005) Insights
into the mRNA cleavage mechanism by MazF, an mRNA interferase.
J. Biol. Chem., 280, 3143–3150.
16. Munoz-Gomez,A.J., Santos-Sierra,S., Berzal-Herranz,A.,
Lemonnier,M. and Diaz-Orejas,R. (2004) Insights into the specificity
of RNA cleavage by the Escherichia coli MazF toxin. FEBS Lett.,
567, 316–320.
17. Christensen,S.K., Pedersen,K., Hansen,F.G. and Gerdes,K. (2003)
Toxin-antitoxin loci as stress-response-elements: ChpAK/MazF and
ChpBK cleave translated RNAs and are counteracted by tmRNA.
J. Mol. Biol., 332, 809–819.
18. Pomerantsev,A.P., Golovliov,I.R., Ohara,Y., Mokrievich,A.N.,
Obuchi,M., Norqvist,A., Kuoppa,K. and Pavlov,V.M. (2001) Genetic
organization of the Francisella plasmid pFNL10. Plasmid, 46,
210–222.
19. Grady,R. and Hayes,F. (2003) Axe-Txe, a broad-spectrum proteic
toxin-antitoxin system specified by a multidrug-resistant, clinical
isolate of Enterococcus faecium. Mol. Microbiol., 47, 1419–1432.
20. Cherny,I., Rockah,L. and Gazit,E. (2005) The YoeB toxin is a folded
protein that forms a physical complex with the unfolded YefM
antitoxin. Implications for a structural-based differential stability of
toxin-antitoxin systems. J. Biol. Chem., 280, 30063–30072.
21. Kamada,K. and Hanaoka,F. (2005) Conformational change in the
catalytic site of the ribonuclease YoeB toxin by YefM antitoxin.
Mol. Cell, 19, 497–509.
22. Christensen,S.K., Maenhaut-Michel,G., Mine,N., Gottesman,S.,
Gerdes,K. and Van Melderen,L. (2004) Overproduction of the Lon
protease triggers inhibition of translation in Escherichia coli:
involvement of the yefM-yoeB toxin-antitoxin system. Mol. Microbiol.,
51, 1705–1717.
23. Ren,D., Bedzyk,L.A., Thomas,S.M., Ye,R.W. and Wood,T.K. (2004)
Gene expression in Escherichia coli biofilms. Appl. Microbiol.
Biotechnol., 64, 515–524.
24. Cherny,I. and Gazit,E. (2004) The YefM antitoxin defines a family of
natively unfolded proteins: implications as a novel antibacterial target.
J. Biol. Chem., 279, 8252–8261.
25. Ruiz-Echevarria,M.J., Berzal-Herranz,A., Gerdes,K. and
Diaz-Orejas,R. (1991) The kis and kid genes of the parD maintenance
system of plasmid R1 form an operon that is autoregulated at the level
of transcription by the co-ordinated action of the Kis and Kid proteins.
Mol. Microbiol., 5, 2685–2693.
26. Magnuson,R. and Yarmolinsky,M.B. (1998) Corepression of the P1
addiction operon by Phd and Doc. J. Bacteriol., 180, 6342–6351.
27. Gotfredsen,M. and Gerdes,K. (1998) The Escherichia coli relBE genes
belong to a new toxin-antitoxin gene family. Mol. Microbiol., 29,
1065–1076.
28. Gazit,E. and Sauer,R.T. (1999) Stability and DNA binding of the Phd
protein of the phage P1 plasmid addiction system. J. Biol. Chem., 274,
2652–2657.
29. Afif,H., Allali,N., Couturier,M. and Van Melderen,L. (2001) The
ratio between CcdA and CcdB modulates the transcriptional
repression of the ccd poison-antidote system. Mol. Microbiol.,
41, 73–82.
30. Marianovsky,I., Aizenman,E., Engelberg-Kulka,H. and Glaser,G.
(2001) The regulation of the Escherichia coli mazEF promoter
involves an unusual alternating palindrome. J. Biol. Chem., 276,
5975–5984.
31. Dao-Thi,M.H., Charlier,D., Loris,R., Maes,D., Messens,J., Wyns,L.
and Backmann,J. (2002) Intricate interactions within the ccd plasmid
addiction system. J. Biol. Chem., 277, 3733–3742.
32. Lemonnier,M., Santos-Sierra,S., Pardo-Abarrio,C. and Diaz-Orejas,R.
(2004) Identification of residues of the Kid toxin involved in
autoregulation of the parD system. J. Bacteriol., 186, 240–243.
33. Zhao,X. and Magnuson,R.D. (2005) Percolation of the Phd
repressor-operator interface. J. Bacteriol., 187, 1901–1912.
34. Simons,R.W., Houman,F. and Kleckner,N. (1987) Improved single and
multicopy lac-based cloning vectors for protein and operon fusions.
Gene, 53, 85–96.
35. Guzman,L.M., Belin,D., Carson,M.J. and Beckwith,J. (1995) Tight
regulation, modulation, and high-level expression by vectors
containing the arabinose PBAD promoter. J. Bacteriol., 177, 4121–4130.
36. Hayes,F., Radnedge,L., Davis,M.A. and Austin,S.J. (1994) The
homologous operons for P1 and P7 plasmid partition are autoregulated
from dissimilar operator sites. Mol. Microbiol., 11, 249–260.
37. Miller,J.H. (1992) A Short Course in Bacterial Genetics: A Laboratory
Manual for Escherichia coli and Related Bacteria. Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY, pp. 72–74.
38. Altschul,S.F., Madden,T.L., Schaffer,A.A., Zhang,J., Zhang,Z.,
Miller,W. and Lipman,D.J. (1997) Gapped BLAST and PSI-BLAST: a
new generation of protein database search programs. Nucleic Acids
Res., 25, 3389–3402.
39. Thompson,J.D., Higgins,D.G. and Gibson,T.J. (1994) CLUSTAL W:
improving the sensitivity of progressive multiple sequence alignment
through sequence weighting, position-specific gap penalties and weight
matrix choice. Nucleic Acids Res., 22, 4673–4680.
40. Linding,R., Russell,R.B., Neduva,V. and Gibson,T.J. (2003) GlobPlot:
exploring protein sequences for globularity and disorder. Nucleic Acids
Res., 31, 3701–3708.
41. Frunzio,R., Bruni,C.B. and Blasi,F. (1981) In vivo and in vitro
detection of the leader RNA of the histidine operon of Escherichia coli
K-12. Proc. Natl Acad. Sci. USA, 78, 2767–2771.
42. Verde,P., Frunzio,R., di Nocera,P.P., Blasi,F. and Bruni,C.B. (1981)
Identification, nucleotide sequence and expression of the regulatory
region of the histidine operon of Escherichia coli K-12. Nucleic Acids
Res., 9, 2075–2086.
43. Patzer,S.I. and Hantke,K. (2000) The zinc-responsive regulator
Zur and its control of the znu gene cluster encoding the ZnuABC
zinc uptake system in Escherichia coli. J. Biol. Chem., 275,
24321–24332.
44. Rojo,F. (2001) Mechanisms of transcriptional repression. Curr. Opin.
Microbiol., 4, 145–151.
45. Zhou,N.E., Kay,C.M. and Hodges,R.S. (1992) Synthetic model
proteins. Positional effects of interchain hydrophobic interactions on
stability of two-stranded a-helical coiled-coils. J. Biol. Chem., 267,
2664–2670.
46. Sreerama,N. and Woody,R.W. (2000) Estimation of protein secondary
structure from circular dichroism spectra: comparison of CONTIN,
SELCON and CDSSTR methods with an expanded reference set.
Anal. Biochem., 287, 252–260.
47. Sprecher,C.A., Baase,W.A. and Johnson,W.C.,Jr (1979) Conformation
and circular dichroism of DNA. Biopolymers, 18, 1009–1019.
48. Santos-Sierra,S., Giraldo,R. and Dı ´az-Orejas,R. (1998) Functional
interactions between chpB and parD, two homologous conditional
killer systems found in the Escherichia coli chromosome and in
plasmid R1. FEMS Microbiol. Lett., 168, 51–58.
49. Erie,D.A., Yang,G., Schultz,H.C. and Bustamante,C. (1994) DNA
bending by Cro protein in specific and nonspecific complexes:
implications for protein site recognition and specificity. Science,
266, 1562–1566.
50. Spronk,C.A., Folkers,G.E., Noordman,A.M., Wechselberger,R., van
den Brink,N., Boelens,R. and Kaptein,R. (1999) Hinge-helix formation
and DNA bending in various lac repressor-operator complexes.
EMBO J., 18, 6472–6480.
51. Akakura,R. and Winans,S.C. (2002) Mutations in the occQ
operator that decrease OccR-induced DNA bending do not
338 Nucleic Acids Research, 2007, Vol. 35, No. 1cause constitutive promoter activity. J. Biol. Chem., 277,
15773–15780.
52. Schumacher,M.A., Miller,M.C., Grkovic,S., Brown,M.H., Skurray,R.A.
and Brennan,R.G. (2002) Structural basis for cooperative DNA binding
by two dimers of the multidrug-binding protein QacR. EMBO J., 21,
1210–1218.
53. Magnuson,R., Lehnherr,H., Mukhopadhyay,G. and Yarmolinsky,M.B.
(1996) Autoregulation of the plasmid addiction operon of
bacteriophage P1. J. Biol. Chem., 271, 18705–18710.
54. Smith,J.A. and Magnuson,R.D. (2004) Modular organization
of the Phd repressor/antitoxin protein. J. Bacteriol., 186,
2692–2698.
Nucleic Acids Research, 2007, Vol. 35, No. 1 339